Expertise in
1
conditions

Dr. Vivek R. Huilgol

Gastroenterology | Hepatology
Phoebe Physician Group Inc
417 W 3rd Ave, 
Albany, GA 
Accepting New Patients
Expertise in
1
conditions
Phoebe Physician Group Inc
417 W 3rd Ave, 
Albany, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vivek Huilgol is a Gastroenterologist and a Hepatologist in Albany, Georgia. Dr. Huilgol is highly rated in 1 condition, according to our data. His top areas of expertise are Intestinal Cancer, Gastrointestinal Bleeding, Diverticular Disease, Endoscopy, and Colonoscopy. Dr. Huilgol is currently accepting new patients.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Hepatology
Licenses
Internal Medicine in NV
Hospital Affiliations
Phoebe Putney Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO

Locations

PHOEBE PHYSICIAN GROUP INC
417 W 3rd Ave, Albany, GA 31701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
Enrollment Status: Completed
Publish Date: September 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Expertise in
95
conditions
Dr. Layth Saymeh
Gastroenterology
Expertise in
95
conditions
Dr. Layth Saymeh
Gastroenterology

Phoebe Physician Group Inc

151 Mayo St, Suite B, 
Americus, GA 
 (33.6 miles away)
229-928-2900
Languages Spoken:
English
See accepted insurances

Layth Saymeh is a Gastroenterologist in Americus, Georgia. Dr. Saymeh is highly rated in 95 conditions, according to our data. His top areas of expertise are Chronic Erosive Gastritis, Gastroesophageal Reflux Disease (GERD), Gastritis, Gastrectomy, and Endoscopy.

Expertise in
15
conditions
Dr. Ira Knepp
Gastroenterology
Expertise in
15
conditions
Dr. Ira Knepp
Gastroenterology
1009 N Monroe St, 
Albany, GA 
 (0.1 miles away)
229-883-0298
Languages Spoken:
English
See accepted insurances

Ira Knepp is a Gastroenterologist in Albany, Georgia. Dr. Knepp is highly rated in 15 conditions, according to our data. His top areas of expertise are Progressive Familial Intrahepatic Cholestasis Type 1, Progressive Familial Intrahepatic Cholestasis Type 2, Visceromegaly, Trichohepatoenteric Syndrome, and Gastrostomy.

Expertise in
4
conditions
Dr. Gandhiji Yalamanchili
Gastroenterology
Expertise in
4
conditions
Dr. Gandhiji Yalamanchili
Gastroenterology
1009 N Monroe St, 
Albany, GA 
 (0.1 miles away)
229-883-0298
Languages Spoken:
English
See accepted insurances

Gandhiji Yalamanchili is a Gastroenterologist in Albany, Georgia. Dr. Yalamanchili is highly rated in 4 conditions, according to our data. His top areas of expertise are Visceromegaly, Enlarged Liver, Cirrhosis, and Esophageal Varices.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Huilgol's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile